Free Trial

agilon health (NYSE:AGL) Shares Gap Down - Should You Sell?

agilon health logo with Medical background

agilon health, inc. (NYSE:AGL - Get Free Report) shares gapped down prior to trading on Thursday . The stock had previously closed at $5.47, but opened at $4.66. agilon health shares last traded at $3.72, with a volume of 2,838,348 shares trading hands.

Analysts Set New Price Targets

AGL has been the subject of a number of recent analyst reports. Cowen reissued a "hold" rating on shares of agilon health in a research report on Tuesday, April 15th. Royal Bank of Canada boosted their price target on agilon health from $3.00 to $3.50 and gave the stock an "outperform" rating in a research note on Wednesday, February 26th. Needham & Company LLC reaffirmed a "hold" rating on shares of agilon health in a research report on Friday, March 21st. TD Cowen boosted their target price on shares of agilon health from $3.50 to $6.00 and gave the stock a "hold" rating in a research report on Tuesday, April 15th. Finally, Stifel Nicolaus raised their price target on shares of agilon health from $2.00 to $3.00 and gave the stock a "hold" rating in a report on Wednesday, February 26th. Two research analysts have rated the stock with a sell rating, thirteen have given a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus price target of $4.60.

Get Our Latest Research Report on AGL

agilon health Trading Down 3.3 %

The company's 50 day moving average price is $4.15 and its 200 day moving average price is $3.12. The firm has a market cap of $1.65 billion, a PE ratio of -4.26 and a beta of 0.38. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29.

Hedge Funds Weigh In On agilon health

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Capital International Investors lifted its stake in agilon health by 72.0% in the fourth quarter. Capital International Investors now owns 22,331,873 shares of the company's stock worth $42,431,000 after acquiring an additional 9,346,295 shares during the last quarter. Millennium Management LLC grew its stake in shares of agilon health by 187.8% during the fourth quarter. Millennium Management LLC now owns 7,212,525 shares of the company's stock worth $13,704,000 after purchasing an additional 4,706,357 shares in the last quarter. Algert Global LLC increased its holdings in agilon health by 1,042.7% in the fourth quarter. Algert Global LLC now owns 2,108,687 shares of the company's stock valued at $4,007,000 after buying an additional 1,924,157 shares during the last quarter. Charles Schwab Investment Management Inc. raised its stake in agilon health by 49.2% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 4,541,549 shares of the company's stock valued at $8,629,000 after buying an additional 1,498,524 shares in the last quarter. Finally, JPMorgan Chase & Co. lifted its holdings in agilon health by 326.4% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company's stock worth $5,563,000 after buying an additional 1,083,492 shares during the last quarter.

agilon health Company Profile

(Get Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Further Reading

Should You Invest $1,000 in agilon health Right Now?

Before you consider agilon health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.

While agilon health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Tech Stocks to Buy Now—And 3 You’ll Regret Keeping
After Stellar Earnings, Is TSMC the Next Chip Leader?
Palantir’s Big Week Reveals a Rare Growth Story in a Shaky Market

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines